See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Liberation Day
Natural Disasters
Baseball
Donald Trump
Social Media
Trade War
Artificial Intelligence
Education
Nintendo
Stock Markets
Senate
Published • loading... • Updated

Beta Bionics (NASDAQ:BBNX) Issues Earnings Results, Misses Estimates By $1.40 EPS

Summary by modernreaders.com
Beta Bionics (NASDAQ:BBNX – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($1.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.42) by ($1.40), Zacks reports. Beta Bionics updated its FY 2025 guidance to EPS. Beta Bionics Stock Performance Shares of BBNX stock traded up $0.37 on Tuesday, hitting $15.22. The company’s stock had a trading volume of 416,428 shares, compared…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
modernreaders.commodernreaders.com

Beta Bionics (NASDAQ:BBNX) Issues Earnings Results, Misses Estimates By $1.40 EPS

Beta Bionics (NASDAQ:BBNX – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($1.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.42) by ($1.40), Zacks reports. Beta Bionics updated its FY 2025 guidance to EPS. Beta Bionics Stock Performance Shares of BBNX stock traded up $0.37 on Tuesday, hitting $15.22. The company’s stock had a trading volume of 416,428 shares, compared…

Read Full Article
Drug Delivery BusinessDrug Delivery Business

Beta Bionics posts Q4 sales beat in 'momentum-building year'

The iLet with the Dexcom G7 (left) and Abbott FreeStyle Libre 3 Plus (right). [Image courtesy of Beta Bionics] Beta Bionics (Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast. Shares of BBNX ticked up nearly 2% to $15.50 apiece in poost-market trading today. This is the company’s first quarterly earnings report after it went public through a $234.6 million IPO in January. The Irvine, Ca…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Drug Delivery Business broke the news in on Tuesday, March 25, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Irvine, California

Irvine, California

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal